type here...

Healthcare

Five New Pieces You Should Read from Chicago Booth Review

Chicago Booth Review recently published its fall issue covering a variety of new research. We suggest five articles from the issue on...
Read more

Healthcare Companies Spent More on Lobbying Than Any Other Industry Last Year

Threatened by regulated price caps from congress, the pharmaceutical industry spent nearly $390 million on lobbying in 2021 according to new data...
Read more

Antitrust Enforcement Is Not Enough to Address Anticompetitive Conduct in Pharmaceutical Markets. Market-Oriented Legal Reform is Needed.

Federal antitrust enforcement has been robust and effective in promoting prescription drug market competition and thereby enhancing consumer welfare. Antitrust enforcement in...
Read more

Competition Problems in Prescription Drug Market

Although not the sole cause of high prescription drug costs, abusive practices that distort competition contribute to the problem. Too many companies...
Read more

The Unchecked Market Power of the American Health Care System

Chicago Booth alumnus and retired health care consultant David W. Ennis responds to ProMarket’s recent coverage on antitrust and the US health...
Read more

Invigorating Competition in Health Care Markets: Is Rate Regulation Needed?

It now appears that market concentration may be the leading cause of America’s health care cost crisis. If the United States is...
Read more

Opening the Black Box: The Hidden Costs of Data-Driven Mergers in Health Care

Vertical data-driven mergers between health insurers and drug suppliers may facilitate health insurers’ efforts to discriminate against vulnerable populations, leaving them without...
Read more

What Is the Price of a Prescription Drug?

Due to lack of transparency and mystery rebates, which are considered trade secrets, figuring out the price of a prescription drug is...
Read more

Covid-19 Is Reducing Americans’ Confidence Across Institutions

Latest US household survey findings reveal that the Covid-19 crisis caused a sharp reduction in Americans’ confidence in institutions—whether or not they...
Read more

Tech Isn’t the Only Sector Deserving of Antitrust Investigation

The House Judiciary Committee’s antitrust report was a missed opportunity. The 450-page report focused solely on digital markets. But what about antitrust...
Read more
12Page 1 of 2

LATEST NEWS

News

The Road to Hayek: A Comprehensive History of Neoliberalism’s Forefather

Bruce J. Caldwell, Hansjoerg Klausinger
In their first of two volumes, economic historians Bruce Caldwell and Hansjoerg Klausinger access new archival material to explore the first fifty...
Read more
News

International Policymaking Must Evolve

Paul Tucker
In this Q&A about his new book for ProMarket, Paul Tucker explains the changing global order and the need for academics, policymakers...
Read more
ESG

Capitalism Does Not Require a Tradeoff Between Planet and Profit

Alessio Terzi
Critics of capitalism claim that the economic system incorrigibly encourages the exploitation of the planet and is thus incompatible with efforts to...
Read more
Academic Capture

Event Notes: Academic Bias Under the Microscope

Andy Shi
That scholarship often reflects conscious and unconscious biases has long been an open secret in academia. On April 22, Professors Christian Leuz,...
Read more
Commentary

Corporations Are Not “We the People”

Geoffrey R. Stone
The Citizens United ruling contradicts the Founders, decades of Supreme Court precedent and the will of the American people.
Read more

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.

About Us

Categories

What we are readingAntitrust and CompetitionNewsRegulatory CaptureMediaRent seeking